| Daily (12/8) | ||
|---|---|---|
| 669 | 11 | 1.6% |
| Total (8/2) | ||
|---|---|---|
| 66,070 | 1,065 | 1.6% |
As the U.S. continues to vaccinate its population at extremely efficient rates, cases around the globe are surging, mostly driven by India and South America. India, a country with a population of nearly 1.4 billion, is seeing daily case counts higher than any other country at any point in the pandemic. Read more
By Capri Fain , Grant Hoover , Vic Verbalaitis and Ellen Nangia | 08/20/2021 9:08am
Taking classes during the pandemic has not been easy, but we have gotten through it. For the year in review edition of the Daily Wildcat, the enterprise desk presents eight stories out of the many lived this year that show the variety of experiences people had in online and COVID-19 precautioned classes. In our print edition there are four out of eight stories — with the rest posted online — from a student and a professor each in four University of Arizona colleges/schools: the College of Nursing, the School of Dance and the School of Theatre, Film and Television from the College of Fine Arts and the James E. Rogers College of Law.
By Kristijan Barnjak | 05/05/2021 11:23am
The University of Arizona’s COVID-19 virtual university status update team met on Monday for its last briefing of the semester. It reflected on the efforts of community volunteers at the state POD site and the recent decline in COVID-19 transmission.
By Jordan White | 04/28/2021 12:49pm
The Daily Wildcat recently spoke with former University of Arizona wide receiver Cedric Peterson via Zoom in an interview.
By Jillian Bartsch | 05/03/2021 10:44pm
It has been a crazy year with many events, changes and Zoom university. However, the news reporters at the Daily Wildcat have worked hard to keep you up to date with everything going on statewide, locally and at the University of Arizona. Let’s take a trip down memory lane.
By Kristijan Barnjak | 04/26/2021 7:08pm
The University of Arizona’s COVID-19 virtual university status update team met Monday, April 26 to discuss the end of the semester and the continued decline in vaccine demand.
By Kristijan Barnjak | 04/20/2021 4:16pm
The University of Arizona’s COVID-19 virtual university status update team met on Monday, April 19, to discuss falling vaccine demand, the UA’s antibody testing initiative and new COVID-19 data.
By Amit Syal | 05/11/2021 12:39am
On Jan. 21, 2020, the U.S. reported its first case of the coronavirus in the state of Washington — a man in his 30s became infected. In the past 15 months, the world has gained an immense amount of knowledge about the coronavirus. Let's take a look at the major developments since then.
By Sean Collins | 04/19/2021 10:16am
While the pandemic continues, so does the University of Arizona's study abroad department’s quick and ever-changing response as it plans to move forward with programs for the summer and fall.
By Amit Syal | 04/24/2021 5:51pm
On Tuesday morning, the Centers for Disease Control and Prevention and the U.S. Food and Drug Administration issued a joint statement calling for a pause on the administration of the Johnson & Johnson (Janssen) coronavirus vaccine. The call came after the two agencies reviewed data involving six reported U.S. cases of a rare and severe type of blood clot in individuals who received the vaccine.
By Grant Hoover and Vic Verbalaitis | 04/13/2021 10:57pm
In this new mini-series from the enterprise desk, people who worked on campus throughout the pandemic share their experiences. This episode, hosts Vic Verbalaitis and Grant Hoover talked with Kennedy Bell, a cashier at the UA Bookstore.
By Kristijan Barnjak | 04/12/2021 11:00pm
The University of Arizona’s COVID-19 virtual university status update team met Monday to discuss vaccination numbers and COVID-19 data.
By Andrea Moreno | 04/11/2021 6:56pm
Vaccine hesitancy in the U.S. is a substantial barrier to achieving herd immunity. The way we are approaching people who are uncertain, especially in the Latino community, is making the problem worse.
By Kristijan Barnjak | 04/07/2021 4:43pm
The University of Arizona’s COVID-19 virtual university status update team met on Monday to discuss new guest policies for graduation and updated COVID-19 data from the UA community.
By Andres Diaz | 04/06/2021 11:10am
Over the past week, coronavirus cases have increased dramatically, and the World Health Organization has announced that new deaths from coronavirus have risen by 5%. Healthcare workers are experiencing the brunt of this surge and are facing mounting mental health challenges as a result.
By Madison Beveridge | 04/05/2021 3:07pm
Across Arizona, bars and restaurants do not have to require guests to wear masks and, with that, crowds are becoming more frequent. As quickly as social gatherings are resuming, vaccines are becoming more accessible. Sitting down with several University of Arizona students, some fully vaccinated and others only on their first dose, revealed how news of these updates is being taken.
By Payton Toomey | 04/05/2021 2:04pm
Arizona Gov. Doug Ducey thinks it's time for Arizona to return to normal, with no pandemic restrictions to speak of. Scientists and reasonable people alike think that this is premature and dangerous.
By Abbie Kosoc | 04/07/2021 2:17pm
The Center for Creative Photography is temporarily closed to the public through the spring semester. Although, their extravagant Finding Meaning exhibit and other collections remain open for online viewing. The curators of the CCP hope that the works can offer a space for community and collective reflection as the pandemic continues.
By Amit Syal | 04/05/2021 2:06pm
On Wednesday morning, Pfizer reported that its coronavirus vaccine, which has been authorized for Americans who are 16 years and older, is 100% effective in children ages 12 to 15. This encouraging news comes as experts warn of another resurgence of coronavirus cases, mostly driven by the younger population.
By Amit Syal | 04/02/2021 10:42am
A new study out of the Centers for Disease Control and Prevention provides strong evidence that the mRNA coronavirus vaccines made by Pfizer and Moderna are highly effective at preventing infection — and not only severe disease — by the novel coronavirus, SARS-CoV-2, in real-world conditions.
